← Back to Search
Design Of Hybrid MnO2‐Polymer‐Lipid Nanoparticles With Tunable Oxygen Generation Rates And Tumor Accumulation For Cancer Treatment
C. Gordijo, A. Z. Abbasi, M. A. Amini, Ho Yin Lip, Azusa Maeda, Ping Cai, P. J. O'Brien, Ralph S Dacosta, Ralph S Dacosta, A. M. Rauth, X. Wu
Published 2015 · Materials Science
Download PDFAnalyze on Scholarcy
Manganese dioxide (MnO2) nanoparticles (NPs) were discovered in previous work to be effective in improving tumor oxygenation (hypoxia) and reducing H2O2 and acidity in the tumor microenvironment (TME) via local injection. To develop MnO2 formulations useful for clinical application, hybrid NPs are designed with tailored hydrophobicity and structure suitable for intravenous injection, with good blood circulation, biocompatibility, high tumor accumulation, and programmable oxygen generation rate. Two different hybrid NPs are constructed by embedding polyelectrolyte-MnO2 (PMD) in hydrophilic terpolymer/protein-MnO2 (TMD) or hydrophobic polymer/lipid-MnO2 (LMD) matrices. The in vitro reactivity of the MnO2 toward H2O2 is controlled by matrix material and NP structure and dependent on pH with up to two-fold higher O2 generation rate at acidic (tumor) pH than at systemic pH. The hybrid NPs are found to be safe to cells in vitro and organs in vivo and effectively decrease tumor hypoxia and hypoxia-inducible-factor-1alpha through local or systemic administration. Fast acting TMD reduces tumor hypoxia by 70% in 0.5 h by local injection. Slow acting LMD exhibits superior tumor accumulation and retention through the systemic administration and decreased hypoxia by 45%. These findings encourage a broader use of hybrid MD NPs to overcome TME factors for cancer treatment.
This paper references
Studies on liver damage induced by nanosized-titanium dioxide in mouse.
Y. Jeon (2013)
Drug resistance and cellular adaptation to tumor acidic pH microenvironment.
Jonathan W. Wojtkowiak (2011)
Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model.
Adam J Shuhendler (2014)
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
J. Chiche (2010)
Dynamics of Hypoxia, Proliferation and Apoptosis after Irradiation in a Murine Tumor Model
A. Ljungkvist (2006)
Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers.
H. L. Wong (2004)
Immunohistochemistry as an Important Tool in Biomarkers Detection and Clinical Practice
L. L. de Matos (2010)
Hypoxia and metabolism: Hypoxia, DNA repair and genetic instability
R. Bristow (2008)
20 , 1404 ; b)
C R Gordijo (2010)
A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System
H. L. Wong (2006)
11 , 2659 ; b)
A J Shuhendler (2013)
Antiangiogenic therapy for breast cancer
D. Nielsen (2010)
NK-Dependent Increases in CCL22 Secretion Selectively Recruits Regulatory T Cells to the Tumor Microenvironment1
A. Mailloux (2009)
Hypoxia and radiation therapy: past history, ongoing research, and future promise.
S. Rockwell (2009)
Glucose‐Responsive Bioinorganic Nanohybrid Membrane for Self‐Regulated Insulin Release
C. Gordijo (2010)
Biogenic manganese oxides: Properties and mechanisms of formation
B. Tebo (2004)
25th anniversary article: metal oxide particles in materials science: addressing all length scales.
D. Koziej (2014)
Investigating Mechanisms of Alkalinization for Reducing Primary Breast Tumor Invasion
I. Robey (2013)
11 , 167 ; b)
S E Rademakers (2009)
Manganese oxide-based materials as electrochemical supercapacitor electrodes.
W. Wei (2011)
The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.
J. Brown (1998)
Radiosensitivity uncertainty evaluation for the in vitro biophysical modeling of EMT6 cells.
M. Oita (2014)
2 , 320 ; f)
A Pottier (2013)
An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.
Y. Shibamoto (1986)
The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol.
K. Teskač (2010)
Toxicology and clinical potential of nanoparticles
L. Yildirimer (2011)
Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α
Y. Kim (2013)
Nanosponge formulations as oxygen delivery systems.
Roberta Cavalli (2010)
Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia
A. Rapisarda (2012)
Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts.
P. Prasad (2013)
The impact of tumor microenvironment on cancer treatment and its modulation by direct and indirect antivascular strategies
E. Fokas (2012)
ZnO nanoparticle-induced oxidative stress triggers apoptosis by activating JNK signaling pathway in cultured primary astrocytes
Jieting Wang (2014)
pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.
A. Shalviri (2012)
Cells Blood Substit
J. W. Wojtkowiak (2011)
Multifunctional nanoparticles--properties and prospects for their use in human medicine.
Nuria Sanvicens (2008)
Nanotechnology‐Enabled Closed Loop Insulin Delivery Device: In Vitro and In Vivo Evaluation of Glucose‐Regulated Insulin Release for Diabetes Control
C. Gordijo (2011)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies.
J. Bottsford-Miller (2012)
Matrigel alters the pathophysiology of orthotopic human breast adenocarcinoma xenografts with implications for nanomedicine evaluation.
Adam J. Shuhendler (2013)
Tumor Hypoxia Predicts Biochemical Failure following Radiotherapy for Clinically Localized Prostate Cancer
M. Milosevic (2012)
A New Polymer–Lipid Hybrid Nanoparticle System Increases Cytotoxicity of Doxorubicin Against Multidrug-Resistant Human Breast Cancer Cells
H. L. Wong (2006)
Hybrid nanoparticles for detection and treatment of cancer.
M. Sailor (2012)
Modulating the tumor microenvironment to increase radiation responsiveness
J. Karar (2009)
The microenvironment and resistance to personalized cancer therapy
S. Masuda (2013)
Improving chemoradiotherapy with nanoparticle therapeutics.
M. Eblan (2013)
Quantification of immunohistochemistry—issues concerning methods, utility and semiquantitative assessment II
C. Taylor (2006)
A novel glucose ENFET based on the special reactivity of MnO2 nanoparticles.
X. Luo (2004)
Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery.
Sarah R MacEwan (2010)
Beyond intercalation-based Li-ion batteries: the state of the art and challenges of electrode materials reacting through conversion reactions.
J. Cabana (2010)
8 , 705 ; d)
A NCSDenko (2006)
Nano titanium dioxide induces the generation of ROS and potential damage in HaCaT cells under UVA irradiation.
Chengbin Xue (2010)
Drug delivery and nanoparticles: Applications and hazards
W. D. de Jong (2008)
Promotion of the hydrogen peroxide decomposition activity of manganese oxide catalysts
M. A. Hasan (1999)
Toxicity assessment of manganese oxide micro and nanoparticles in Wistar rats after 28 days of repeated oral exposure
S. Singh (2013)
Safety assessment of nanomaterials: implications for nanomedicine.
Andreas M. Nystroem (2012)
59 , 491 ; b)
H L Wong
Mechanism for α -MnO 2 Nanowire-Induced Cytotoxicity in Hela Cells
Y. Li (2010)
New use of metals as nanosized radioenhancers.
A. Pottier (2014)
Radiation-Induced Vascular Damage in Tumors: Implications of Vascular Damage in Ablative Hypofractionated Radiotherapy (SBRT and SRS)
H. Park (2012)
Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging
H. Zhang (2006)
Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
H. L. Wong (2006)
Hemoglobin-based Oxygen Carriers Combined with Anticancer Drugs May Enhance Sensitivity of Radiotherapy and Chemotherapy to Solid Tumors
W. Wu (2009)
Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells.
H. Yuan (2008)
Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
M. Mimeault (2013)
Regulation of cancer cell metabolism
R. Cairns (2011)
A multifunctional polymeric nanotheranostic system delivers doxorubicin and imaging agents across the blood-brain barrier targeting brain metastases of breast cancer.
J. Li (2014)
Nanoparticle-blood interactions: the implications on solid tumour targeting.
James Lazarovits (2015)
The Range of Uncertainty: a Tool for Efficiently Addressing Result Variability Around Clinical Decision Points for Hepatitis C Response-guided Therapy
P. Jülicher (2014)
31 , 823 ; b) J. Karar , A. Maity
E Fokas (1994)
Increasing sensitivity to radiotherapy and chemotherapy by using novel biological agents that alter the tumor microenvironment.
E. Shinohara (2009)
Design of pH-responsive nanoparticles of terpolymer of poly(methacrylic acid), polysorbate 80 and starch for delivery of doxorubicin.
A. Shalviri (2013)
Drug resistance and the solid tumor microenvironment.
O. Trédan (2007)
Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.
Jin-Wook Yoo (2010)
Evaluation of Azathioprine-Induced Cytotoxicity in an In Vitro Rat Hepatocyte System
A. Maruf (2014)
Hypoxia, HIF1 and glucose metabolism in the solid tumour
N. Denko (2008)
A Review of Porous Manganese Oxide Materials
S. Brock (1998)
Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
H. L. Wong (2007)
A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
Adam J Shuhendler (2012)
A microenvironmental model of carcinogenesis
R. Gatenby (2008)
Multifunctional albumin-MnO₂ nanoparticles modulate solid tumor microenvironment by attenuating hypoxia, acidosis, vascular endothelial growth factor and enhance radiation response.
P. Prasad (2014)
Hydrogen peroxide in the human body
B. Halliwell (2000)
Multifunctional terpolymeric MRI contrast agent with superior signal enhancement in blood and tumor.
A. Shalviri (2013)
This paper is referenced by
Synthesis and characterization of hyaluronic acid coated manganese dioxide microparticles that act as ROS scavengers.
J. Bizeau (2017)
A novel pH-responsive electrochemiluminescence immunosensor for ALV-J detection based on hollow MnO2 encapsulating Ru(bpy)3Cl2.
C. Liu (2018)
Advances in nanomaterials for treatment of hypoxic tumor
Mei-Zhen Zou (2020)
Hybrid Nanomedicine Fabricated from Photosensitizer-Terminated Metal-Organic Framework Nanoparticles for Photodynamic Therapy and Hypoxia-Activated Cascade Chemotherapy.
Zhimei He (2019)
A black phosphorus/manganese dioxide nanoplatform: Oxygen self-supply monitoring, photodynamic therapy enhancement and feedback.
Jintong Liu (2019)
Construction of smart inorganic nanoparticle-based ultrasound contrast agents and their biomedical applications
M. Ma (2015)
Specific-oxygen-supply functionalized core-shell nanoparticles for smart mutual-promotion between photodynamic therapy and gambogic acid-induced chemotherapy.
Lingfei Han (2020)
A heavy atom-free copolymer for light triggered photodynamic and photothermal therapy of human prostate cancer cells
Jian Shen (2019)
Targeted Magnetic Resonance Imaging and Modulation of Hypoxia with Multifunctional Hyaluronic Acid-MnO2 Nanoparticles in Glioma.
Chaoping Fu (2019)
Reprogramming Tumor Associated Macrophages toward M1 Phenotypes with Nanomedicine for Anticancer Immunotherapy
X. Xu (2020)
Injectable redox and light responsive MnO2 hybrid hydrogel for simultaneous melanoma therapy and multidrug-resistant bacteria-infected wound healing.
S. Wang (2020)
Functional Graphene Oxide-Based Nanosheets for Photothermal Therapy
J. H. Lim (2018)
Nanomedicine‐Enabled Modulation of Tumor Hypoxic Microenvironment for Enhanced Cancer Therapy
Jinping Wang (2020)
Albumin-stabilized manganese-based nanocomposites with sensitive tumor microenvironment responsivity and their application for efficient SiRNA delivery in brain tumors.
K. Xu (2020)
Bottom-Up Synthesis of Metal-Ion-Doped WS₂ Nanoflakes for Cancer Theranostics.
Liang Cheng (2015)
Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
Guangbao Yang (2017)
Construction of Smart Manganese Dioxide‐Based All‐in‐One Nanoplatform for Cancer Diagnosis and Therapy
Xiangmei Liu (2020)
eview n the use of nanotechnology-based strategies for association of omplex matrices from plant extracts iovanni
Konat Zorzia (2015)
Modulation of Hypoxia in Solid Tumor Microenvironment with MnO2 Nanoparticles to Enhance Photodynamic Therapy
W. Zhu (2016)
Inorganic Nanozyme with Combined Self-Oxygenation/Degradable Capabilities for Sensitized Cancer Immunochemotherapy
J. Wang (2019)
Mesoporous carbon‑manganese nanocomposite for multiple imaging guided oxygen-elevated synergetic therapy.
X. Li (2019)
Characterization, catalyzed water oxidation and anticancer activities of a NIR BODIPY-Mn polymer.
Ya-Quan Lan (2017)
Oxygen-generating hybrid nanoparticles to enhance fluorescent/photoacoustic/ultrasound imaging guided tumor photodynamic therapy.
Shi Gao (2017)
Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia.
A. Sahu (2019)
Dimerization of heavy atom free tetraphenylethylene with aggregation induced emission for boosting photodynamic therapy
Jianjiao Chen (2020)
Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy – an illustration with firsthand examples
R. Zhang (2018)
Nanostructured manganese dioxide for anticancer applications: preparation, diagnosis, and therapy.
Z. Zhang (2020)
Advances in controlled gas-releasing nanomaterials for therapeutic applications
D. Manoharan (2019)
Multifunctional bioreactive-nanoconstructs for sensitive and accurate MRI of cerebrospinal fluid pathology and intervention of Alzheimer’s disease
Chunsheng He (2020)
H2O2-responsive theranostic nanomedicine
Luodan Yu (2017)
Controllable growth of Au nanostructures onto MoS2 nanosheets for dual-modal imaging and photothermal-radiation combined therapy.
Teng Liu (2019)
Near-Infrared-Triggered in Situ Gelation System for Repeatedly Enhanced Photothermal Brachytherapy with a Single Dose.
Zhouqi Meng (2018)See more